1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Tumor Targeting Nanodelivery Systems: Expanding Potential for Cancer Therapy and Diagnosis"}],["$","meta","1",{"name":"description","content":"NCI Nanotechnology Seminar Series\n

\nThe National Cancer Institute is organizing a series of lectures that will feature speakers from throughout the cancer research community. These distinguished speakers will share their innovative perspectives on current research and development efforts in the field of nanotechnology and their application to cancer diagnosis, treatment and prevention.\n

\nFor more information, visit
\nhttp://nano.cancer.gov/events_nanotech_seminar_series.asp\n

\nDr. Chang serves as Basic Science co-Leader of the Molecular Targets and Development Therapeutics (MTDT) Program at Lombardi Comprehensive Cancer Center. Her research efforts focus primarily on the molecular mechanisms of carcinogenesis, and in translating this basic information into new clinical modalities. "}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Tumor Targeting Nanodelivery Systems: Expanding Potential for Cancer Therapy and Diagnosis"}],["$","meta","4",{"property":"og:description","content":"NCI Nanotechnology Seminar Series\n

\nThe National Cancer Institute is organizing a series of lectures that will feature speakers from throughout the cancer research community. These distinguished speakers will share their innovative perspectives on current research and development efforts in the field of nanotechnology and their application to cancer diagnosis, treatment and prevention.\n

\nFor more information, visit
\nhttp://nano.cancer.gov/events_nanotech_seminar_series.asp\n

\nDr. Chang serves as Basic Science co-Leader of the Molecular Targets and Development Therapeutics (MTDT) Program at Lombardi Comprehensive Cancer Center. Her research efforts focus primarily on the molecular mechanisms of carcinogenesis, and in translating this basic information into new clinical modalities. "}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/9869d9ec-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/77dca106-f311-48fe-bf07-e0067726cfd2.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Tumor Targeting Nanodelivery Systems: Expanding Potential for Cancer Therapy and Diagnosis"}],["$","meta","11",{"name":"twitter:description","content":"NCI Nanotechnology Seminar Series\n

\nThe National Cancer Institute is organizing a series of lectures that will feature speakers from throughout the cancer research community. These distinguished speakers will share their innovative perspectives on current research and development efforts in the field of nanotechnology and their application to cancer diagnosis, treatment and prevention.\n

\nFor more information, visit
\nhttp://nano.cancer.gov/events_nanotech_seminar_series.asp\n

\nDr. Chang serves as Basic Science co-Leader of the Molecular Targets and Development Therapeutics (MTDT) Program at Lombardi Comprehensive Cancer Center. Her research efforts focus primarily on the molecular mechanisms of carcinogenesis, and in translating this basic information into new clinical modalities. "}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}